Duopharma Biotech Berhad's latest marketcap:
As of 06/08/2025, Duopharma Biotech Berhad's market capitalization has reached $313.29 M. According to our data, Duopharma Biotech Berhad is the 17072th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 313.29 M |
| Revenue (ttm) | 208.5 M |
| Net Income (ttm) | 17.23 M |
| Shares Out | 961.94 M |
| EPS (ttm) | 0.02 |
| Forward PE | 14.20 |
| Ex-Dividend Date | 03/05/2025 |
| Earnings Date | 05/16/2025 |
Duopharma Biotech Berhad's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/08/2025 | RM1.33 B | 10.4% |
| 12/31/2024 | RM1.2 B | -0.79% |
| 12/29/2023 | RM1.21 B | -20.94% |
| 12/30/2022 | RM1.53 B | -3.1% |
| 12/31/2021 | RM1.58 B | -33.7% |
| 12/31/2020 | RM2.39 B |
Company Profile
About Duopharma Biotech Berhad
Duopharma Biotech Berhad is an investment holding company specializing in the research, development, manufacturing, and distribution of pharmaceutical products and medicines. Operating in Malaysia and internationally, the company serves a diverse range of healthcare needs.
Product Offerings
The company provides a broad portfolio of healthcare solutions, including:
- Consumer Healthcare: Vitamins, supplements, analgesics, eyecare, antacids, and skincare products.
- Generic Drugs: Covering therapeutic classes such as cardiovascular, dermatology, respiratory, and more.
- Specialty Pharmaceuticals: Targeted treatments for diabetes, cancer, renal diseases, and other conditions.
- Biosimilar Products & Medical Devices: Including insugen, basalog one, and other specialized solutions.
Key Brands
Duopharma Biotech markets its products under well-known brands such as:
- Champs
- Flavettes
- Eye Glo
- Proviton
- Naturalle
- Uphamol
Additional Services
Beyond pharmaceuticals, the company engages in:
- Property management and services
- Distribution, import, and export of chemical products
Company Background
Originally founded in 1978 as CCM Duopharma Biotech Berhad, the company rebranded to its current name in February 2019. Headquartered in Kuala Lumpur, Malaysia, Duopharma Biotech continues to expand its global footprint in the healthcare industry.
Frequently Asked Questions
-
What is Duopharma Biotech Berhad's (KLSE-DPHARMA) current market cap?As of 06/08/2025, Duopharma Biotech Berhad (including the parent company, if applicable) has an estimated market capitalization of $313.29 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Duopharma Biotech Berhad (KLSE-DPHARMA) rank globally by market cap?Duopharma Biotech Berhad global market capitalization ranking is approximately 17072 as of 06/08/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.